On May 30, 2024, Marksans Pharma Ltd, one of the leading pharmaceutical companies in India, released its results for the quarter and year ended March 31, 2024. Quarterly Performance Operating revenue was ₹560.0 crore, up 15.2% YoY due to new product launches, increased share with current customers, volume gains, and client additions. With a 51.8% …